Petros Pharmaceuticals's total assets for Q1 2025 were $17.61M, an increase of 65.54% from the previous quarter. PTPI total liabilities were $27.19M for the fiscal quarter, a 50.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.